Ah CJ Only if you accept that "they will still only be selling <1% of the amount they need to, if in fact, they meet their own projections". I recommend that you follow your own advice and "DYOR".
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%